These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37405219)

  • 1. Hypothyroidism With ACTH Deficiency During Pembrolizumab Therapy for Lung Cancer: Case Report and Literature Review.
    Hashinokuchi A; Haro A; Minagawa R; Haruta Y; Kawano H; Suehiro T; Sugimachi K
    Cancer Diagn Progn; 2023; 3(4):498-503. PubMed ID: 37405219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].
    Gu YC; Liu Y; Xie C; Cao BS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):369-375. PubMed ID: 35435206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated adrenocorticotropic hormone deficiency associated with sintilimab therapy in a patient with advanced lung adenocarcinoma: a case report and literature review.
    Lin SH; Zhang A; Li LZ; Zhao LC; Wu LX; Fang CT
    BMC Endocr Disord; 2022 Sep; 22(1):239. PubMed ID: 36153581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated ACTH deficiency during single-agent pembrolizumab for squamous cell lung carcinoma: a case report.
    Tanaka S; Kushimoto M; Nishizawa T; Takubo M; Mitsuke K; Ikeda J; Fujishiro M; Ogawa K; Tsujino I; Suzuki Y; Abe M
    Clin Diabetes Endocrinol; 2020; 6():1. PubMed ID: 31921440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of Hypopituitarism and Hypothyroidism after Treatment with Pembrolizumab in a Patient with Adrenal Metastasis from Non-small-cell Lung Cancer.
    Yamagata S; Kageyama K; Takayasu S; Asari Y; Makita K; Terui K; Daimon M
    Intern Med; 2019 Dec; 58(24):3557-3562. PubMed ID: 31462588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothyroidism and hypopituitarism as immune-related adverse events due to lenvatinib plus pembrolizumab therapy in the immediate postoperative period after laparoscopic hepatectomy for liver metastases from gastric cancer: a case report.
    Sasaki K; Kobayashi S; Kudo M; Sugimoto M; Takahashi S; Nakamura Y; Kawazoe A; Shitara K; Kinoshita T; Gotohda N
    Surg Case Rep; 2021 Dec; 7(1):267. PubMed ID: 34928436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
    Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
    J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary hypothyroidism and isolated ACTH deficiency induced by nivolumab therapy: Case report and review.
    Zeng MF; Chen LL; Ye HY; Gong W; Zhou LN; Li YM; Zhao XL
    Medicine (Baltimore); 2017 Nov; 96(44):e8426. PubMed ID: 29095280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pembrolizumab-induced secondary adrenal insufficiency due to adrenocorticotrophic hormone deficiency in a patient with non-small-cell lung carcinoma: a case report.
    Fujimiya T; Azuma K; Togashi Y; Kuwata K; Unezaki S; Takeuchi H
    J Pharm Health Care Sci; 2024 Feb; 10(1):10. PubMed ID: 38365819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of nivolumab-induced isolated adrenocorticotropic hormone (ACTH) deficiency.
    Sato Y; Tanaka Y; Hino M; Seike M; Gemma A
    Respir Med Case Rep; 2019; 26():223-226. PubMed ID: 30740300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report.
    Takeno A; Yamamoto M; Morita M; Tanaka S; Kanazawa I; Yamauchi M; Kaneko S; Sugimoto T
    BMC Endocr Disord; 2019 Feb; 19(1):25. PubMed ID: 30782163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pembrolizumab-induced hypothyroidism caused reversible increased serum creatinine levels: a case report.
    Matsuoka N; Tsuji K; Ichihara E; Hara T; Fukushima K; Toma K; Kitamura S; Inagaki K; Sugiyama H; Wada J
    BMC Nephrol; 2020 Mar; 21(1):113. PubMed ID: 32234009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pembrolizumab- and ipilimumab-induced diabetic ketoacidosis and isolated adrenocorticotropic hormone deficiency: a case report.
    Porntharukchareon T; Tontivuthikul B; Sintawichai N; Srichomkwun P
    J Med Case Rep; 2020 Sep; 14(1):171. PubMed ID: 32988414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 Diabetes, ACTH Deficiency, and Hypothyroidism Simultaneously Induced by Nivolumab Therapy in a Patient with Gastric Cancer: A Case Report.
    Marshall S; Kizuki A; Kitaoji T; Imada H; Kato H; Hosoda M; Ishikawa M; Sakura H
    Case Rep Oncol; 2020; 13(3):1185-1190. PubMed ID: 33173483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non-small-cell lung cancer.
    Kurokawa K; Mitsuishi Y; Shimada N; Ito N; Ogiwara M; Miura K; Asao T; Ko R; Shukuya T; Shibayama R; Goto H; Takahashi K
    Thorac Cancer; 2023 Feb; 14(5):442-449. PubMed ID: 36523162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of Empty Sella syndrome with adrenal insufficiency masked by prednisolone after administration of immune checkpoint inhibitors.
    Iwamoto Y; Tatsumi F; Ohnishi M; Katakura Y; Kimura T; Shimoda M; Nakanishi S; Mune T; Kaneto H
    Medicine (Baltimore); 2024 Mar; 103(10):e37204. PubMed ID: 38457550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Central Hypothyroidism and Adrenal Insufficiency Associated with Retinoic Acid Therapy for Cutaneous T-Cell Lymphoma.
    Marino A; Albanese I; Larose S; Fantus IG
    AACE Clin Case Rep; 2022; 8(6):251-254. PubMed ID: 36447824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When Hormones are Being Difficult: A Rare Case and the Literature Review of Pembrolizumab-Induced Polyendocrinopathy.
    Tayyeb M; Tariq M; Khan AM; Khalid F; Meghal T; Du D
    J Community Hosp Intern Med Perspect; 2023; 13(6):90-94. PubMed ID: 38596553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: a new case and literature review.
    Oğuz SH; Ünlütürk U; Aksoy S; Erbas T
    Immunotherapy; 2021 Oct; 13(14):1157-1163. PubMed ID: 34387129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotoxicosis and Adrenocortical Hormone Deficiency During Immune-checkpoint Inhibitor Treatment for Malignant Melanoma.
    Ariyasu H; Inaba H; Ota T; Yamaoka H; Furukawa Y; Iwakura H; Doi N; Yamamoto Y; Akamizu T
    In Vivo; 2018; 32(2):345-351. PubMed ID: 29475919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.